BACKGROUND: The aims of this study were to investigate the following questions: (I) what are the mortality rates in patients age 55 years and younger who underwent a hip resurfacing arthroplasty (HRA) versus a standard total hip arthroplasty (THA)? (II) is the type of operation independently associated with mortality? METHODS: The database of a single high-volume surgeon was reviewed for patient's age 55 years and younger who underwent a hip arthroplasty between 2002 and 2010. This yielded 505 HRA patients and 124 THA patients. Chi-square analysis was performed to identify a 5-year mortality rate difference between the two cohorts. Multivariable Cox-Regression analyses were used to determine whether the type of operation was independently associated with mortality. RESULTS: There were 8 mortalities (1.6%) in the HRA cohort and 11 (8.9%) in the THA cohort, a statistically significant difference (P<0.001) on univariate analysis. Low mortality rates produced underpowered multivariate models. CONCLUSIONS: We have demonstrated that patients age 55 and younger who undergo HRA have a significantly lower mortality rate than those undergoing THA. This is consistent with multiple previously published large database studies.
BACKGROUND: The aims of this study were to investigate the following questions: (I) what are the mortality rates in patients age 55 years and younger who underwent a hip resurfacing arthroplasty (HRA) versus a standard total hip arthroplasty (THA)? (II) is the type of operation independently associated with mortality? METHODS: The database of a single high-volume surgeon was reviewed for patient's age 55 years and younger who underwent a hip arthroplasty between 2002 and 2010. This yielded 505 HRA patients and 124 THA patients. Chi-square analysis was performed to identify a 5-year mortality rate difference between the two cohorts. Multivariable Cox-Regression analyses were used to determine whether the type of operation was independently associated with mortality. RESULTS: There were 8 mortalities (1.6%) in the HRA cohort and 11 (8.9%) in the THA cohort, a statistically significant difference (P<0.001) on univariate analysis. Low mortality rates produced underpowered multivariate models. CONCLUSIONS: We have demonstrated that patients age 55 and younger who undergo HRA have a significantly lower mortality rate than those undergoing THA. This is consistent with multiple previously published large database studies.
Entities:
Keywords:
Birmingham Hip Resurfacing (BHR); Mortality; hip resurfacing; total hip arthroplasty (THA)
Authors: Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik Journal: JAMA Date: 2011-01-05 Impact factor: 56.272
Authors: Michael A Mont; Thorsten M Seyler; Phillip S Ragland; Roland Starr; Jochen Erhart; Anil Bhave Journal: J Arthroplasty Date: 2007-01 Impact factor: 4.757
Authors: Adeel Aqil; Roshan Drabu; Jeroen H Bergmann; Milad Masjedi; Victoria Manning; Barry Andrews; Sarah K Muirhead-Allwood; Justin P Cobb Journal: Int Orthop Date: 2013-02-27 Impact factor: 3.075
Authors: Matti Seppänen; Mikko Karvonen; Petri Virolainen; Ville Remes; Pekka Pulkkinen; Antti Eskelinen; Antti Liukas; Keijo T Mäkelä Journal: Acta Orthop Date: 2016-10-19 Impact factor: 3.717
Authors: Nahal Mansouri; Gareth R Willis; Angeles Fernandez-Gonzalez; Monica Reis; Sina Nassiri; S Alex Mitsialis; Stella Kourembanas Journal: JCI Insight Date: 2019-11-01